Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Neuropathic Pain market size was valued at USD 9263.0 million in 2022 and is expected to expand at a CAGR of 4.87% during the forecast period, reaching USD 12324.0 million by 2028.
Limitations
In recent years, there has been almost no difference between firstline and second-line therapies for the treatment of NP. Most recommendations for first-line and second-line treatment are based on antidepressants and anti-epileptic drugs. The clinical situation of neuropathic pain is complex, the etiology and pathophysiology are different, so the advantage of neuropathic pain is difficult to judge and treat. At present, the best means for treating neuropathic pain and its pathological conditions is still not recognized. This may include reasons for the relatively late understanding of neuropathic pain itself, and it is difficult to establish clear diagnostic criteria; there is a lack of well-designed large-scale clinical trials to evaluate the effectiveness of drugs for the treatment of neuropathic pain. Due to the lack of systematic treatment of neuropathic pain, treatment strategies are generally based on inaccurate evidence and very few clinical trials. The research process is relatively slow, and the cost of research is high. The drug approval process is long, which will result in market development. Certainly affected.
Region Overview:
From 2023-2028, United States is estimated to witness robust growth prospects.
Company Overview:
The top three companies are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson Services Inc. with the revenue market share of 50.87%, 4.70%, 4.23% in 2018.
Pfizer is the world's largest research-based pharmaceutical company. The company operates three business units: healthcare, animal health and consumer care. The company's biggest source of income is prescription drugs. Pfizer's large drugs include the antidepressant Zoloft and the lipid-lowering drug Lipitor, the world's best-selling drug. Pfizer's products are sold in more than 150 countries.
Lilly was founded in 1876. Eli Lilly is committed to developing high quality medicines that meet actual needs. Provide products and services to 125 countries around the world.
Segmentation Overview:
Among different product types, Peripheral Neuropathy segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Hospitals segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Neuropathic Pain industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Neuropathic Pain. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Neuropathic Pain Market Report Include:
Market Size Estimates: Neuropathic Pain market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Neuropathic Pain market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Neuropathic Pain market
Segment Market Analysis: Neuropathic Pain market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Neuropathic Pain market situations and prospects in major and top regions and countries
Neuropathic Pain Market
Neuropathic Pain Industry Chain: Neuropathic Pain market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Neuropathic Pain Industry News, Policies by regions
Neuropathic Pain Industry Porters Five Forces Analysis
Key players in the global Neuropathic Pain market are covered in Chapter 2:
Novartis AG
Eli Lilly and Company
Arbor Pharmaceuticals
Endo
Johnson & Johnson Services Inc.
Pfizer, Inc.
Grunenthal Group
Abbott Laboratories
In Chapter 6 and Chapter 9, on the basis of types, the Neuropathic Pain market from 2018 to 2028 is primarily split into:
Peripheral Neuropathy
Entrapment Neuropathy
Phantom Limb Pain
Trigeminal Neuralgia
Post Herpetic Neuralgia (PHN)
Post Traumatic Neuropathy
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Neuropathic Pain market from 2018 to 2028 covers:
Hospitals
Clinics
Research Organizations
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Neuropathic Pain market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Neuropathic Pain industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Neuropathic Pain market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Neuropathic Pain industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Neuropathic Pain market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Neuropathic Pain market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Neuropathic Pain market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Limitations
In recent years, there has been almost no difference between firstline and second-line therapies for the treatment of NP. Most recommendations for first-line and second-line treatment are based on antidepressants and anti-epileptic drugs. The clinical situation of neuropathic pain is complex, the etiology and pathophysiology are different, so the advantage of neuropathic pain is difficult to judge and treat. At present, the best means for treating neuropathic pain and its pathological conditions is still not recognized. This may include reasons for the relatively late understanding of neuropathic pain itself, and it is difficult to establish clear diagnostic criteria; there is a lack of well-designed large-scale clinical trials to evaluate the effectiveness of drugs for the treatment of neuropathic pain. Due to the lack of systematic treatment of neuropathic pain, treatment strategies are generally based on inaccurate evidence and very few clinical trials. The research process is relatively slow, and the cost of research is high. The drug approval process is long, which will result in market development. Certainly affected.
Region Overview:
From 2023-2028, United States is estimated to witness robust growth prospects.
Company Overview:
The top three companies are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson Services Inc. with the revenue market share of 50.87%, 4.70%, 4.23% in 2018.
Pfizer is the world's largest research-based pharmaceutical company. The company operates three business units: healthcare, animal health and consumer care. The company's biggest source of income is prescription drugs. Pfizer's large drugs include the antidepressant Zoloft and the lipid-lowering drug Lipitor, the world's best-selling drug. Pfizer's products are sold in more than 150 countries.
Lilly was founded in 1876. Eli Lilly is committed to developing high quality medicines that meet actual needs. Provide products and services to 125 countries around the world.
Segmentation Overview:
Among different product types, Peripheral Neuropathy segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Hospitals segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Neuropathic Pain industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Neuropathic Pain. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Neuropathic Pain Market Report Include:
Market Size Estimates: Neuropathic Pain market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Neuropathic Pain market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Neuropathic Pain market
Segment Market Analysis: Neuropathic Pain market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Neuropathic Pain market situations and prospects in major and top regions and countries
Neuropathic Pain Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Neuropathic Pain Industry Chain: Neuropathic Pain market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Neuropathic Pain Industry News, Policies by regions
Neuropathic Pain Industry Porters Five Forces Analysis
Key players in the global Neuropathic Pain market are covered in Chapter 2:
Novartis AG
Eli Lilly and Company
Arbor Pharmaceuticals
Endo
Johnson & Johnson Services Inc.
Pfizer, Inc.
Grunenthal Group
Abbott Laboratories
In Chapter 6 and Chapter 9, on the basis of types, the Neuropathic Pain market from 2018 to 2028 is primarily split into:
Peripheral Neuropathy
Entrapment Neuropathy
Phantom Limb Pain
Trigeminal Neuralgia
Post Herpetic Neuralgia (PHN)
Post Traumatic Neuropathy
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Neuropathic Pain market from 2018 to 2028 covers:
Hospitals
Clinics
Research Organizations
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Neuropathic Pain market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Neuropathic Pain industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Neuropathic Pain market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Neuropathic Pain industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Neuropathic Pain market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Neuropathic Pain market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Neuropathic Pain market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
